Mesenchymal stem cell therapy as a game-changer in liver diseases: review of current clinical trials

Summary Chronic liver diseases, including cirrhosis and liver failure, remain formidable challenges due to their complex progression and limited therapeutic options. Mesenchymal stem cell (MSC) therapy has emerged as a game-changing approach, leveraging its potent immunomodulatory, anti-fibrotic, an...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Wei-Chen Huang, Yuan-Chi Li, Pin-Xuan Chen, Kevin Sheng-Kai Ma, Li-Tzu Wang
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2025-01-01
Edice:	Stem Cell Research & Therapy
Témata:	Mesenchymal stem cells (MSCs) Immunomodulation Anti-fibrosis Transdifferentiation Liver cirrhosis End-stage liver diseases
On-line přístup:	https://doi.org/10.1186/s13287-024-04127-y
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!